breastfeeding on glp 1 GLP-1: Safety & Clinical Considerations – PlexusDx GLP-1 Receptor Agonist Use Across

Patients taking semaglutide can lose 15% to 20% of their body weight over the course of a year

Oakley AJ, Lo Bello M, Battistoni A, Ricci G, Rossjohn J, Villar HO et al

These medications are based on modified human GLP-1 sequences, though their development was inspired by the proof-of-concept established through the exendin-4 discovery

Maternal exposure to GLP-1 receptor agonists during pregnancy was not associated with a statistically significant increase in the overall risk of congenital disabilities, with an odds ratio (OR) of 1.11 and a 95% confidence interval (CI) of 0.82-1.51

Sunscreen plays a huge role here

Macrophage polarization from M1 to M2 Macrophages exist on a spectrum